Overview and Usage
Brand name – Gefticip
Generic name – Gefitinib
Manufacturer – CIPLA
Strength – 250mg
Dosage Form – Tablet
Composition – Gefitinib
Indication – Lung Cancer
Storage – at 20° – 25° C
Overview of Gefticip 250mg tablet
Gefticip 250mg tablet is a chemotherapy medication that is used in the treatment of non-small cell lung cancer (NSCLC). The generic name of this medication is Gefitinib. It is a tyrosine kinase inhibitor that shows antineoplastic activity. Gefticip is used in the first-line treatment of lung cancer that has genetic mutations.
Pharmacodynamics
Gefticip functions by blocking the action of EGFR tyrosine kinase which binds to the ATP binding site of the enzyme. EGFR refers to epidermal growth factor receptor and it is often overexpressed in cancerous cells, which furthermore leads to stimulation of anti-apoptotic signals. In addition, it causes cell proliferation as well. Gefticip has antineoplastic activity hence it stops the growth and spreading of cancer cells.


